sobuzoxane has been researched along with Lymphoma, T-Cell in 3 studies
sobuzoxane: used in treatment of leukemia L1210
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnishi, K | 1 |
| Ohno, R | 1 |
| Okamoto, T | 1 |
| Nishimura, Y | 1 |
| Yamada, S | 2 |
| Itoh, T | 1 |
| Mori, A | 1 |
| Saheki, K | 1 |
| Okada, M | 1 |
| Takatsuka, H | 1 |
| Wada, H | 1 |
| Tamura, A | 1 |
| Fujimori, Y | 1 |
| Kakishita, E | 1 |
| Honda, S | 1 |
| Ito, Y | 1 |
| Otawa, M | 1 |
| Katagiri, T | 1 |
| Kuriyama, Y | 1 |
| Serizawa, H | 1 |
| Ebihara, Y | 1 |
| Mukai, K | 1 |
| Ohyashiki, K | 1 |
2 reviews available for sobuzoxane and Lymphoma, T-Cell
| Article | Year |
|---|---|
[New antitumor drugs for malignant lymphoma: a review].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; | 1994 |
[CD56- and CD4-positive non-Hodgkin's lymphoma of probable T-cell origin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; | 2001 |
1 other study available for sobuzoxane and Lymphoma, T-Cell
| Article | Year |
|---|---|
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 2000 |